Ruth P, Flockerzi V, von Nettelbladt E, Oeken J, Hofmann F
Eur J Biochem. 1985 Jul 15;150(2):313-22. doi: 10.1111/j.1432-1033.1985.tb09023.x.
The bovine cardiac sarcolemmal binding sites for the dihydropyridine nimodipine and the phenylalkylamine (-)-desmethoxyverapamil were studied. The density of the nimodipine and (-)-desmethoxyverapamil binding sites increased 8.3-fold and 3.4-fold with the sarcolemma. The binding sites for both compounds were destroyed by trypsin. Nimodipine bound in the presence of 1 mM free calcium to a high-affinity and a low-affinity site with apparent Kd values of 0.35 +/- 0.09 nM (n = 9) and 33 +/- 6.0 nM (n = 9) and with apparent densities of 0.3 +/- 0.05 pmol/mg (n = 9) and 8.2 +/- 1.0 pmol/mg (n = 9). The binding to the high-affinity site was abolished by 1 mM EGTA. The binding sites were specific for dihydropyridines. The (-)-isomers of several phenylalkylamines inhibited nimodipine binding by an apparent allosteric mechanism. (-)-Desmethoxyverapamil bound in the presence of 5 mM EGTA to a high-affinity and a low-affinity site with apparent Kd values of 1.4 +/- 0.3 nM (n = 6) and 171 +/- 26 nM (n = 6) and with apparent densities of 0.16 +/- 0.02 pmol/mg (n = 6) and 13.6 +/- 2.7 pmol/mg (n = 6). The binding to both sites was inhibited by calcium with a half-maximal concentration of 4.3 mM. The binding sites were specific for the other phenylalkylamines and had a higher affinity for the (-)-isomers than for the (+)-isomers. Nimodipine inhibited the binding of (-)-desmethoxyverapamil by an apparent allosteric mechanism. d-cis-Diltiazem inhibited non-competitively the binding of (-)-[3H]desmethoxyverapamil with a Ki of 3.7 microM. Diltiazem up to concentrations of 10 microM did not affect the amount of nimodipine bound at equilibrium at 20 degrees C. However, but in agreement with this result, diltiazem decreased threefold at 20 degrees C the dissociation and association rates for the high-affinity nimodipine receptor. These rates were only marginally affected at 4 degrees C and 37 degrees C. d-cis-Diltiazem reversed in a competitive manner the inhibition of nimodipine binding elicited by the addition of (-)-desmethoxyverapamil with a Ka value of 1.6 microM. The amount of nimodipine bound was inhibited by 50% by the adenosine uptake inhibitors nitrobenzylthioinosine and hexobendine with apparent median inhibitory concentrations of 1 nM and 3 nM, respectively. Nitrobenzylthioinosine completely abolished binding of nimodipine to the low-affinity site, but did not affect binding to the high-affinity site.(ABSTRACT TRUNCATED AT 400 WORDS)
对二氢吡啶尼莫地平和苯烷基胺(-)-去甲氧基维拉帕米在牛心肌肌膜上的结合位点进行了研究。尼莫地平和(-)-去甲氧基维拉帕米结合位点的密度随肌膜分别增加了8.3倍和3.4倍。两种化合物的结合位点都被胰蛋白酶破坏。在1 mM游离钙存在下,尼莫地平与一个高亲和力位点和一个低亲和力位点结合,表观解离常数(Kd)值分别为0.35±0.09 nM(n = 9)和33±6.0 nM(n = 9),表观密度分别为0.3±0.05 pmol/mg(n = 9)和8.2±1.0 pmol/mg(n = 9)。1 mM乙二醇双四乙酸(EGTA)可消除与高亲和力位点的结合。这些结合位点对二氢吡啶具有特异性。几种苯烷基胺的(-)-异构体通过明显的变构机制抑制尼莫地平的结合。在5 mM EGTA存在下,(-)-去甲氧基维拉帕米与一个高亲和力位点和一个低亲和力位点结合,表观Kd值分别为1.4±0.3 nM(n = 6)和171±26 nM(n = 6),表观密度分别为0.16±0.02 pmol/mg(n = 6)和13.6±2.7 pmol/mg(n = 6)。钙以4.3 mM的半数最大浓度抑制与两个位点的结合。这些结合位点对其他苯烷基胺具有特异性,对(-)-异构体的亲和力高于对(+)-异构体的亲和力。尼莫地平通过明显的变构机制抑制(-)-去甲氧基维拉帕米的结合。d-顺式地尔硫卓非竞争性抑制(-)-[3H]去甲氧基维拉帕米的结合,抑制常数(Ki)为3.7 μM。在20℃时,浓度高达10 μM的地尔硫卓不影响平衡时结合的尼莫地平的量。然而,与此结果一致的是,在20℃时,地尔硫卓使高亲和力尼莫地平受体的解离和结合速率降低了三倍。在4℃和37℃时,这些速率仅受到轻微影响。d-顺式地尔硫卓以竞争性方式逆转了因添加(-)-去甲氧基维拉帕米而引起的尼莫地平结合抑制,解离常数(Ka)值为1.6 μM。腺苷摄取抑制剂硝基苄硫基肌苷和己氧苯啶分别以1 nM和3 nM的表观半数抑制浓度使结合的尼莫地平量减少50%。硝基苄硫基肌苷完全消除了尼莫地平与低亲和力位点的结合,但不影响与高亲和力位点的结合。(摘要截短于400字)